LCLuz Ángela Castro

Luz Ángela Castro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luz Ángela Castro has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nail dermatophytoma in HIV-infected patients in Cali, Colombia

    by Luz Ángela Castro, María Inés Álvarez


  • Open Access

    Candida auris infection in the central catheter of a patient without sepsis symptoms

    by Luz Angela Castro, María Inés Álvarez, Gustavo Giusiano, Ernesto Martínez

    Background: Candida auris is an emerging yeast frequently reported as resistant to multiple antifungal drugs commonly used to treat Candida infections. This specie can colonize the patient’s skin and has great ability for producing outbreaks in hospitals. C. auris is phylogenetically related to other Candida species, can be misidentified using conventional biochemical or commercial methods and requires specific technology for its identification. Case report: We report the first isolate of C. auris in Cali, Colombia, from a central venous catheter in a 37-year-old patient with rheumatoid arthritis and endocarditis who did not have symptoms of sepsis. The yeast was initially misidentified as C. haemulonii using the Phoenix® system and subsequently identified as C. auris by matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry. The broth microdilution method was used to determine the minimum inhibitory concentration; the isolate was susceptible to fluconazole, itraconazole, voriconazole and amphotericin B. Conclusions: This report contributes to knowledge of the epidemiology of C. auris infections in individuals with underlying disease and describes an isolate with a behavior different from what is usually reported.


    • 30 December 2015
      • Vol. 46  (4) , 202-203
    Open Access

    Laryngeal histoplasmosis: report of the first case in Colombia

    by Luz Angela Castro Alegria

  • Open Access

    Laryngeal histoplasmosis: report of the first case in Colombia

    by Luz Angela Castro

    Dear Editor, With regard to the article "Laryngeal histoplasmosis: report of the first case in Colombia" published by Moriones et al. Colomb Med (Cali). 2014; 45(4):186-9 1 , we would like to provide the following comments: Histoplasmosis is a common systemic mycosis in Colombia, and because no reporting requirements exist, a national survey was designed to understand aspects of the disease that could be collected from diagnosed cases to provide useful information. A total of 434 patient surveys from 20 departments were analyzed through 2008; the majority of the reports were from Antioquia, followed by del Valle and Cundinamarca. Thus, the results from these surveys did not indicate that histoplasmosis is more commonly diagnosed in these departments, as the authors had expressed, but rather that these were the most informative departments 2, as this was a voluntary report.

  • Open Access

    Candida en la cavidad oral de pacientes con VIH en Cali, Colombia: determinación de especies y sensibilidad al fluconazol

    by Luz Angela Castroalegria, Maria Ines Alvarezvalle, Ernesto Martinezbuitrago

    Candida en la cavidad oral de pacientes con VIH en Cali, Colombia: determinación de especies y sensibilidad al fluconazol


  • Pseudomembranous Candidiasis in HIV/AIDS Patients in Cali, Colombia

    by Luz Ángela Castro, María Inés Álvarez, Ernesto Martínez

    Candida albicans is the most frequently isolated yeast from the oral cavity of HIV/AIDS individuals. The use of fluconazole has increased the number of resistant or less-sensitive Candida species different than C. albicans. The purpose of this study was to identify the Candida species producing pseudomembranous candidiasis in patients suffering from AIDS, their relationship with CD4+ counts and their sensitivity to fluconazole and itraconazole. We studied 71 patients at a hospital in the city of Cali. Samples of white plaque were seeded on CHROMagar Candida, yeast identification was done with API 20C Aux, and susceptibility testing was determined by E test. Ninety-three yeast isolates were obtained, 52 single and 41 mixed. C. albicans was the most isolated, followed by C. glabrata. An increased frequency of isolates and variety of Candida species occurred in patients with a CD4+ cell count ≤100 cells/mm3 without significant differences (p = 0.29). The susceptibility study showed that 8 (8.6 %) isolates were resistant to fluconazole and 11 (11.8 %) to itraconazole, while 6 (8.8 %) C. albicans were simultaneously resistant. No association was found between the isolates of C. albicans or Candida species different than C. albicans and the use of fluconazole (p = 0.21). The results of this study indicate that in the tested population, fluconazole continues to be the best treatment option for oropharyngeal candidiasis in patients suffering from AIDS (HIV/AIDS); however, susceptibility tests are necessary in patients who present therapeutic failure.


  • Onychomycosis in Cali, Colombia

    by María Inés Alvarez, Luz Ángela González, Luz Ángela Castro

    This study presents the epidemiological and mycological aspects of 299 patients with nail lesions who were referred to three diagnostic laboratories in the city of Cali. The diagnosis of mycoses was...